Philip Katz

ID: 1b834083-2619-30fb-68c4

/

Unclaimed

/

Organization: Hogan Lovells

FDA Announces Policy for Unique Nonproprietary Names for Biologics and Biosimilars

Focus on Regulation · August 31, 2015

FDA Publishes Final Guidance on Physical Attributes of Generics

Focus on Regulation · June 18, 2015

FDA Publishes Draft Guidances and Memorandum of Understanding on Drug Compounding and Repackaging

Focus on Regulation · February 23, 2015

Major FDA Announcement on OTCs

Focus on Regulation · February 24, 2014

FDA Issues Draft Guidance on Size and Shape of Generic Tablets and Capsules

Focus on Regulation · December 10, 2013